Immunopathogenesis of juvenile rheumatoid arthritis

Current Opinion in Rheumatology

Volumn 11, Issue 5, 1999, Pages 377-383

  Moore, Terry L ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

CYTOKINE RELEASE; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CYTOKINES; HUMANS;

EID: 0032707607     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199909000-00009     Document Type: Review

References (31)

1. Jarvis JN: Pathogenesis and mechanisms of inflammation in the childhood rheumatic diseases. Curr Opin Rheumatol 1998, 10:459-467.
2. De Benedetti F, Ravelli A, Martini A: Cytokines in juvenile rheumatoid arthritis. Curr Opin Rheumatol 1997, 9:428-433.
3. Mossman TR, Coffmann RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173.
4. Raziuddin S, Bahabri S, Al-Dalaan A, Siraj AK, Al-Sedairy S: A mixed Th1/Th2 cell cytokine response predominates in systemic-onset juvenile rheumatoid arthritis: Immunoregulatory IL-10 function. Clin Immunol Immunopathol 1998, 86:192-198.
5. Delespesse G, Suter U, Mossalayi D: Expression, structure, and function of the CD23 antigen. Adv Immunol 1991, 49:149-191.
6. Massa M, Pignatti P, Olivari M, De Amici M, De Benedetti F, Martini A: Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis. Clin Exp Rheumatol 1998, 16:611-616.
7. Lecoanet-Henchoz S, Gauchat JF, Aubrey IP: CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 1995, 3:119-125.
8. Kutukculer N, Caglayan S: Plasma and synovial fluid soluble CD23 concentrations in children with juvenile chronic arthritis. Autoimmunity 1998, 27:155-158.
9. Ozen S, Tucker LB, Miller LC: Identification of Th subsets in juvenile rheumatoid arthritis confirmed by intracellular cytokines staining. J Rheumatol 1998, 25:1651-1653.
10. Gattorno M, Facchetti P, Ghiotto F, Vignola S, Buoncompagni A, Prigione I, Picco P, Pistoia V: Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/ThO-type pattern of cytokine secretion irrespective of immunophenoltypic. Clin Exp Immunol 1997, 109:4-11.
11. Zhang H, Phang B, Laxer RM, Silverman ED, Pan S, Doherty PJ: Evolution of the T cell receptor-β repertoire from synovial fluid T cells of patients with juvenile onset rheumatoid arthritis. J Rheumatol 1997, 24:1396-1402.
12. Thomas R, Lipsky PE: Presentation of self-peptides by dendritic cells: possible implications for the pathogenesis of rheumatoid arthritis. Arthritis Rheum 1996, 39:183-190.
13. Thompson SD, Murray KJ, Gromm AA, Passo MH, Choi E, Glass DN: Comparative sequence analysis of the human T cell receptor β chain in juvenile rheumatoid arthritis and juvenile spondyloarthropathies. Arthritis Rheum 1998, 41:482-497.
14. Khalkhali-Ellis Z, Roodman ST, Knutsen AP, Mueller KR, Chauhan B, Moore TL, Hendrix MJC: Expression of macrophage markers by a population of T cells obtained from synovial fluid in a subgroup of patients with juvenile rheumatoid arthritis. J Rheumatol 1998, 25:352-360.
15. Madson KL, Moore TL, Lawrence JM, Osborn TG: Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 1994, 21:2359-2363.
16. De Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A: Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 1991, 34:1158-1163.
17. De Benedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A: Serum soluble IL-6 receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994, 93:2114-2119.
18. De Benedetti F, Pignatti P, Gerloni V, Massa M, Sartirana P, Caporali R, Montecucco CM, Corti A, Fantini F, Martini A: Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis. J Rheumatol 1997, 24:1403-1409.
19. De Benedetti F, Martini A: Is systemic juvenile rheumatoid arthritis an interleukin-6 mediated disease? J Rheumatol 1998, 25:203-207. An excellent editorial on the role of IL-6 in systemic JRA.
20. Picco P, Gattorno M, Buoncompagni A, Facchetti P, Rossi G, Pistoia V: Prolactin and interleukin-6 in prepubertal girls with juvenile chronic arthritis. J Rheumatol 1998, 25:347-351.
21. Fishmann D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369-1376.
22. Kutukculer N, Caglayan S, Aydogdu F: Study of pro-inflammatory (TNF-α, IL-1α, IL-6) and T-cell derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: Correlations with clinical and laboratory parameters. Clin Rheumatol 1998, 17:288-292.
23. Gattorno M, Picco P, Buoncompagni A, Stalla F, Facchetti P, Sormani MP, Pistoia V: Serum p55 and p75 tumor necrosis factor receptors as markers of disease activity in juvenile chronic arthritis. Ann Rheum Dis 1996, 55:243-247.
24. Murray KJ, Grom AA, Thompson SD, Lieuwen D, Passo MH, Glass DN: Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin-4 in restricted disease. J Rheumatol 1998, 25:1388-1398.
25. De Benedetti F, Pignatti P, Bernasconi S, Gerloni V, Matsushima K, Caporali R, Montecucco CM, Sozzani S, Fantini F, Martini A: Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis: relation to onset types, disease activity, and synovial fluid leukocytes. J Rheumatol 1999, 26:425-431.
26. Gattorno M, Picco P, Vignola S, Stalla F, Buoncompagni A, Pistoia V: Serum interteukin 12 concentration in juvenile chronic arthritis. Ann Rheum Dis 1998, 57:425-428.
27. Khalkhali-Ellis Z, Seftor EA, Nieva DRC, Seftor REB, Samaha HAM, Bullman L, DeLarco JE, Ince A, Moore TL, Hendrix MJC: Induction of invasive and degradative phenotype in normal synovial fibroblasts exposed to synovial fluid from patients with juvenile rheumatoid arthritis: Role of mononuclear cell population. J Rheumatol 1997, 24:2451-2460.
28. Sioud M, Mellbye O, Forre O: Analysis of the NF-Kβ p65 subunit, Fas antigen, Fas ligand and Bcl-2 related proteins in the synovium of RA and polyarticular JRA. Clin Exp Rheum 1998, 16:125-134.
29. Lovell DJ, Giannini EH, Whitmore JB, Soffes L, Finck BK: Safety and efficacy of tumor necrosis factor receptor p75 Fc fusion protein in polyarticular course juvenile rheumatoid arthritis. Arthritis Rheum 1998, 41 [suppl]:S130.
30. Khalkhali-Ellis Z, Moore TL, Hendrix MJC: Reduced levels of testosterone and dehydroepiandrosterone sulfate in the serum and synovial fluid of juvenile rheumatoid arthritis patients correlates with disease severity. Clin Exp Rheum 1998, 16:753-756.
31. Tselepis AD, Elisaf M, Besis S, Karabina S-AP, Chapman MJ, Siamopoulou A: Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high density lipoproteinemia and reduced lipoprotein-associated platelet activating factor, acetylhydroase activity. Arthritis Rheum 1999, 42:373-383.